Download MendeleyFirst comprehensive structural and biophysical analysis of MAPK13 inhibitors targeting DFG-in and DFG-out binding modes.
Yurtsever, Z., Patel, D.A., Kober, D.L., Su, A., Miller, C.A., Romero, A.G., Holtzman, M.J., Brett, T.J.(2016) Biochim Biophys Acta 1860: 2335-2344
- PubMed: 27369736
- DOI: https://doi.org/10.1016/j.bbagen.2016.06.023
- Primary Citation of Related Structures:
5EKN, 5EKO - PubMed Abstract:
P38 MAP kinases are centrally involved in mediating extracellular signaling in various diseases. While much attention has previously been focused on the ubiquitously expressed family member MAPK14 (p38α), recent studies indicate that family members such as MAPK13 (p38δ) display a more selective cellular and tissue expression and might therefore represent a specific kinase to target in certain diseases.
Organizational Affiliation:
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, United States; Center for the Investigation of Membrane Excitability Diseases, Washington University School of Medicine, St. Louis, MO 63110, United States; Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, MO 63110, United States; Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, MO 63110, United States. Electronic address: tbrett@wustl.edu.
